Press release
Strategic Forecast for the Calcitonin Injection Industry: Market Outlook 2025-2034
Calcitonin Injection
Calcitonin Injection Market Size Growth Forecast: What to Expect by 2025?
In recent times, the market for calcitonin injections has experienced substantial growth. The size of the market is projected to rise from $0.67 billion in 2024 to $0.73 billion in 2025, with a compound annual growth rate (CAGR) of 8.5%. Factors such as increasing cases of osteoporosis, growing awareness about bone health, broader options for postmenopausal treatments, accessibility of government healthcare subsidies, and an increase in the older population are contributing to the growth witnessed in the historic period.
How Will the Calcitonin Injection Market Size Evolve and Grow by 2029?
In the next few years, the calcitonin injection market is projected to witness robust growth, escalating to $0.99 billion by 2029, reflecting a compound annual growth rate (CAGR) of 8.2%. This expansion during the prediction period is credited to the surging demand for treatments, the emergence of biosimilar competitors, increased demand in nascent markets, a shift towards personalized healthcare, and extensive research into alternative uses for calcitonin. The forecast period will also observe significant trends such as progress in intranasal and injectable delivery methods, advanced formulations with prolonged half-lives, the creation of biosimilar calcitonin goods, breakthroughs in osteoporosis treatment approaches, and advancements in diagnostic equipment.
View the full report here:
https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report
What Drivers Are Propelling the Growth of Calcitonin Injection Market Forward?
The upsurge in osteoporosis rates is anticipated to fuel the calcitonin injection market expansion. Osteoporosis, a condition typified by a decline in bone density and heightened risk of fractures, predominantly impacts aged individuals, specifically postmenopausal women. The growing incidence of osteoporosis can be attributed to greater life expectancies, which result in inevitable loss of bone density and elevated disease risk. Calcitonin injection plays a significant role in osteoporosis management by controlling calcium levels and decelerating bone loss, hence acting efficiently in maintaining bone density. These injections, which are simple to administer, facilitate targeted treatment, enhance patient adherence, and minimize the risk of fractures. For example, per the Australian Institute of Health and Welfare in June 2024, 853,600 people (or 3.4%) in Australia were living with osteoporosis or osteopenia in 2022, leading to 2,659 deaths, or 1.4% of all deaths. Consequently, the rising prevalence of osteoporosis is spurring the expansion of the calcitonin injection market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp
Which Emerging Trends Are Transforming the Calcitonin Injection Market in 2025?
Leading firms in the calcitonin injection market are channeling their efforts into the creation of groundbreaking products such as USP synthetic injections to enhance therapeutic results and ameliorate patient health outcomes. USP Synthetic Injections are medicines meant for injection, comprising synthetically crafted active ingredients which comply with the rigorous standards for quality, purity, potency, and identity as established by the United States Pharmacopeia (USP). These injections are produced under tightly controlled environments to guarantee that they're safe and therapeutically effective. For instance, February 2025 saw Fresenius Kabi, a pharmaceutical firm based in Germany, bring to market its calcitonin salmon injection, a USP synthetic, indicated for treating the symptoms of Paget's bone disease and hypercalcemia. This sterile solution, which is engineered for intramuscular or subcutaneous application, comes in a strength of 200 USP units per mL in a 2 mL multi-dose vial that holds 400 USP units. The product must be kept cool between temperatures of 2°C and 8°C. This injection serves as a calcium regulator and is recommended for treating symptomatic Paget's bone disease when conventional treatments fail to suffice, hypercalcemia, and postmenopausal osteoporosis when other alternatives don't measure up.
What Are the Key Segments in the Calcitonin Injection Market?
The calcitonin injection market covered in this report is segmented -
1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin
2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection
3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions
4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy
5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare
Subsegments:
1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin
2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin
3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24490&type=smp
Who Are the Key Players Shaping the Calcitonin Injection Market's Competitive Landscape?
Major companies operating in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy's Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB
What Geographic Markets Are Powering Growth in the Calcitonin Injection Market?
North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24490
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Strategic Forecast for the Calcitonin Injection Industry: Market Outlook 2025-2034 here
News-ID: 4092730 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Calcitonin
Salmon Calcitonin Market Analysis and Future Prospects for 2030
The world of the salmon calcitonin market is a complex and ever-evolving landscape, shaped by consumer demands and technological advancements. In this report, we delve into the depths of this market to provide a profound and comprehensive analysis, catering to a diverse audience that includes manufacturers, suppliers, distributors, and investors. Our primary goal is to empower industry stakeholders with invaluable insights to make informed decisions in a rapidly changing environment.…
Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Recept …
Market Research Hub (MRH) has added a new report titled “Calcitonin Gene Related Peptide Type 1 Receptor, Pharmaceutical Pipeline Research Report” to its vast data repository. Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) pipeline Target constitutes close to 14 molecules. Out of which approximately 14 molecules are developed by Companies. The latest report Calcitonin Gene Related Peptide Type 1 Receptor - Pipeline Review, H1…
Calcitonin Salmon Market Development Status and Outlook 2026
Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In fish, birds, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg…
Calcitonin Salmon Market : Trends, outlook and Opportunity Analysis 2026
Key players in the calcitonin salmon market include Novartis AG, Apotex, Inc., Upsher-Smith Laboratories, Inc., Alkem Laboratories Ltd., Torrent Pharmaceuticals Limited, Glenmark Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., and United Biotech (P) Limited.
Novartis AG, Upsher-Smith Laboratorie, Inc., and Torrent Pharmaceuticals are the leading players in the global calcitonin salmon market.
Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In fish, birds,…
Calcitonin Salmon Market to Register Substantial Expansion by 2026
Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In fish, birds, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg…
Calcitonin Salmon Market : Global Analysis, Opportunities and Forecast To 2026
Calcitonin, also called thyrocalcitonin, is a linear polypeptide hormone produced in human thyroid glands by parafollicular cells. In fish, birds, and other non-mammalian animals, calcitonin is produced by cells of ultimobranchial body. Calcitonin lowers the levels of calcium and phosphate in blood and promotes the bone formation. Calcitonin inhibits the bone removal cells called osteoclasts and simultaneously promotes bone formation cells called osteoblasts. The potency of calcitonin salmon per mg…
